Objective: To evaluate whether the use of indocyanine green fluorescence angiography was associated with a reduced risk of anastomotic leak after rectosigmoid resection in patients undergoing cytoreductive surgery for FIGO stage III–IV epithelial ovarian cancer. Methods: We performed a single-center retrospective cohort study of consecutive patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal cancer who underwent primary or interval cytoreductive surgery with rectosigmoid resection and anastomosis between January 2009 and December 2023. Patients treated from 2020-2023 underwent indocyanine green fluorescence angiography in addition to conventional perfusion assessment; those treated from 2009-2019 underwent conventional perfusion assessment (visual inspection of anastomotic tension and intraoperative air leak testing) alone. Multivariable logistic regressions were used to identify predictors of anastomotic leak. Results: Among 795 patients included, 556 (70.0%) underwent surgery before indocyanine green fluorescence angiography adoption and 239 (30.0%) after. Overall, 45 patients (5.7%) developed an anastomotic leak. Leak rates were significantly lower in the ICG group compared with the no–ICG group (2.5% vs 7.0%; P = .01). In multivariable analysis, use of indocyanine green fluorescence angiography was independently associated with a lower risk of anastomotic leak (odds ratio [OR], 0.37; 95% CI, 0.14–0.83; P = .03). Conclusion: In this retrospective cohort study of patients undergoing cytoreductive surgery for stage III–IV ovarian cancer, use of indocyanine green fluorescence angiography was independently associated with a significantly lower rate of rectosigmoid anastomotic leak compared to conventional assessment. These findings support the use of indocyanine green fluorescence angiography as an adjunct intraoperative tool to reduce the risk of anastomotic leak.

Schivardi, G., Ribero, L., Rosanu, M., Fumagalli, D., Taliento, C., Caruso, G., et al. (2026). Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER [10.1016/j.ijgc.2026.104951].

Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study

Gaeta A.;
2026

Abstract

Objective: To evaluate whether the use of indocyanine green fluorescence angiography was associated with a reduced risk of anastomotic leak after rectosigmoid resection in patients undergoing cytoreductive surgery for FIGO stage III–IV epithelial ovarian cancer. Methods: We performed a single-center retrospective cohort study of consecutive patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal cancer who underwent primary or interval cytoreductive surgery with rectosigmoid resection and anastomosis between January 2009 and December 2023. Patients treated from 2020-2023 underwent indocyanine green fluorescence angiography in addition to conventional perfusion assessment; those treated from 2009-2019 underwent conventional perfusion assessment (visual inspection of anastomotic tension and intraoperative air leak testing) alone. Multivariable logistic regressions were used to identify predictors of anastomotic leak. Results: Among 795 patients included, 556 (70.0%) underwent surgery before indocyanine green fluorescence angiography adoption and 239 (30.0%) after. Overall, 45 patients (5.7%) developed an anastomotic leak. Leak rates were significantly lower in the ICG group compared with the no–ICG group (2.5% vs 7.0%; P = .01). In multivariable analysis, use of indocyanine green fluorescence angiography was independently associated with a lower risk of anastomotic leak (odds ratio [OR], 0.37; 95% CI, 0.14–0.83; P = .03). Conclusion: In this retrospective cohort study of patients undergoing cytoreductive surgery for stage III–IV ovarian cancer, use of indocyanine green fluorescence angiography was independently associated with a significantly lower rate of rectosigmoid anastomotic leak compared to conventional assessment. These findings support the use of indocyanine green fluorescence angiography as an adjunct intraoperative tool to reduce the risk of anastomotic leak.
Articolo in rivista - Articolo scientifico
Anastomotic Leak; Cytoreductive Surgery; Indocyanine Green Fluorescence Angiography; Ovarian Cancer; Rectosigmoid Resection
English
7-ago-2026
2026
104951
reserved
Schivardi, G., Ribero, L., Rosanu, M., Fumagalli, D., Taliento, C., Caruso, G., et al. (2026). Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER [10.1016/j.ijgc.2026.104951].
File in questo prodotto:
File Dimensione Formato  
Schivardi et al-2026-International Journal of Gynecological Cancer-Preprint.pdf

Solo gestori archivio

Tipologia di allegato: Submitted Version (Pre-print)
Licenza: Tutti i diritti riservati
Dimensione 914.28 kB
Formato Adobe PDF
914.28 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/628407
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
Social impact